Literature DB >> 15650214

Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

Shixia Wang1, Te-hui W Chou, Pavlo V Sakhatskyy, Song Huang, John M Lawrence, Hong Cao, Xiaoyun Huang, Shan Lu.   

Abstract

The Spike (S) protein of the severe acute respiratory syndrome-associated coronavirus (SARS-CoV) plays important roles in viral pathogenesis and potentially in the development of an effective vaccine against this virulent infectious disease. In this study, the codon-optimized S gene of SARS-CoV was synthesized to construct DNA vaccine plasmids expressing either the full-length or segments of the S protein. High titer S-specific immunoglobulin G antibody responses were elicited in rabbits immunized with DNA against various segments of the S protein. Two neutralizing domains were identified on the S protein, one at the N terminus (Ser12-Thr535) and the other near the C terminus (Arg797-Ile1192).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15650214      PMCID: PMC544123          DOI: 10.1128/JVI.79.3.1906-1910.2005

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Identification of an antigenic determinant on the S2 domain of the severe acute respiratory syndrome coronavirus spike glycoprotein capable of inducing neutralizing antibodies.

Authors:  Hong Zhang; Guangwen Wang; Jian Li; Yuchun Nie; Xuanling Shi; Gewei Lian; Wei Wang; Xiaolei Yin; Yang Zhao; Xiuxia Qu; Mingxiao Ding; Hongkui Deng
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

2.  An exposed domain in the severe acute respiratory syndrome coronavirus spike protein induces neutralizing antibodies.

Authors:  Tong Zhou; Hong Wang; Danlin Luo; Thomas Rowe; Zheng Wang; Robert J Hogan; Shihong Qiu; Robert J Bunzel; Guoqiang Huang; Vinod Mishra; Thomas G Voss; Robert Kimberly; Ming Luo
Journal:  J Virol       Date:  2004-07       Impact factor: 5.103

3.  Structural characterization of the fusion-active complex of severe acute respiratory syndrome (SARS) coronavirus.

Authors:  Paolo Ingallinella; Elisabetta Bianchi; Marco Finotto; Giovanna Cantoni; Debra M Eckert; Vinit M Supekar; Chiara Bruckmann; Andrea Carfi; Antonello Pessi
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-25       Impact factor: 11.205

4.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice.

Authors:  Zhi-Yong Yang; Wing-Pui Kong; Yue Huang; Anjeanette Roberts; Brian R Murphy; Kanta Subbarao; Gary J Nabel
Journal:  Nature       Date:  2004-04-01       Impact factor: 49.962

Review 5.  Identifying epitopes of HIV-1 that induce protective antibodies.

Authors:  Susan Zolla-Pazner
Journal:  Nat Rev Immunol       Date:  2004-03       Impact factor: 53.106

6.  Interaction between heptad repeat 1 and 2 regions in spike protein of SARS-associated coronavirus: implications for virus fusogenic mechanism and identification of fusion inhibitors.

Authors:  Shuwen Liu; Gengfu Xiao; Yibang Chen; Yuxian He; Jinkui Niu; Carlos R Escalante; Huabao Xiong; James Farmar; Asim K Debnath; Po Tien; Shibo Jiang
Journal:  Lancet       Date:  2004-03-20       Impact factor: 79.321

7.  Proteomic analysis on structural proteins of Severe Acute Respiratory Syndrome coronavirus.

Authors:  Wantao Ying; Yunwei Hao; Yangjun Zhang; Wenming Peng; Ede Qin; Yun Cai; Kaihua Wei; Jie Wang; Guohui Chang; Wei Sun; Shujia Dai; Xiaohai Li; Yunping Zhu; Jianqi Li; Songfeng Wu; Lihai Guo; Jingquan Dai; Jinglan Wang; Ping Wan; Tinggui Chen; Chunjuan Du; Dong Li; Jia Wan; Xuezhang Kuai; Weihua Li; Rong Shi; Handong Wei; Cheng Cao; Man Yu; Hong Liu; Fangting Dong; Donggen Wang; Xuemin Zhang; Xiaohong Qian; Qingyu Zhu; Fuchu He
Journal:  Proteomics       Date:  2004-02       Impact factor: 3.984

8.  A DNA vaccine producing LcrV antigen in oligomers is effective in protecting mice from lethal mucosal challenge of plague.

Authors:  Shixia Wang; Destin Heilman; Fangjun Liu; Theodore Giehl; Swati Joshi; Xiaoyun Huang; Te-hui Chou; Jon Goguen; Shan Lu
Journal:  Vaccine       Date:  2004-09-03       Impact factor: 3.641

9.  A 193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2.

Authors:  Swee Kee Wong; Wenhui Li; Michael J Moore; Hyeryun Choe; Michael Farzan
Journal:  J Biol Chem       Date:  2003-12-11       Impact factor: 5.157

10.  Structural characterization of the SARS-coronavirus spike S fusion protein core.

Authors:  Brian Tripet; Megan W Howard; Michael Jobling; Randall K Holmes; Kathryn V Holmes; Robert S Hodges
Journal:  J Biol Chem       Date:  2004-03-02       Impact factor: 5.157

View more
  52 in total

Review 1.  Animal origins of the severe acute respiratory syndrome coronavirus: insight from ACE2-S-protein interactions.

Authors:  Wenhui Li; Swee-Kee Wong; Fang Li; Jens H Kuhn; I-Chueh Huang; Hyeryun Choe; Michael Farzan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

2.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

3.  Human neutralizing Fab molecules against severe acute respiratory syndrome coronavirus generated by phage display.

Authors:  Xiaoping Kang; Bao-An Yang; Yuyang Hu; Hui Zhao; Wei Xiong; Yinhui Yang; Bingyin Si; Qingyu Zhu
Journal:  Clin Vaccine Immunol       Date:  2006-08

Review 4.  Emerging respiratory viruses: challenges and vaccine strategies.

Authors:  Laura Gillim-Ross; Kanta Subbarao
Journal:  Clin Microbiol Rev       Date:  2006-10       Impact factor: 26.132

5.  DNA vaccine prime followed by boost with live attenuated virus significantly improves antigen-specific T cell responses against human cytomegalovirus.

Authors:  Anna Gil; Siyuan Shen; Scott Coley; Laura Gibson; Don J Diamond; Shixia Wang; Shan Lu
Journal:  Hum Vaccin Immunother       Date:  2013-07-25       Impact factor: 3.452

6.  Single amino acid substitutions in the severe acute respiratory syndrome coronavirus spike glycoprotein determine viral entry and immunogenicity of a major neutralizing domain.

Authors:  Christopher E Yi; Lei Ba; Linqi Zhang; David D Ho; Zhiwei Chen
Journal:  J Virol       Date:  2005-09       Impact factor: 5.103

7.  Specific asparagine-linked glycosylation sites are critical for DC-SIGN- and L-SIGN-mediated severe acute respiratory syndrome coronavirus entry.

Authors:  Dong P Han; Motashim Lohani; Michael W Cho
Journal:  J Virol       Date:  2007-08-22       Impact factor: 5.103

8.  Immunogenicity and protection efficacy of subunit-based smallpox vaccines using variola major antigens.

Authors:  Pavlo Sakhatskyy; Shixia Wang; Chuanyou Zhang; Te-Hui Chou; Michael Kishko; Shan Lu
Journal:  Virology       Date:  2007-10-24       Impact factor: 3.616

Review 9.  Progress on the induction of neutralizing antibodies against HIV type 1 (HIV-1).

Authors:  Michael Vaine; Shan Lu; Shixia Wang
Journal:  BioDrugs       Date:  2009       Impact factor: 5.807

Review 10.  The spike protein of SARS-CoV--a target for vaccine and therapeutic development.

Authors:  Lanying Du; Yuxian He; Yusen Zhou; Shuwen Liu; Bo-Jian Zheng; Shibo Jiang
Journal:  Nat Rev Microbiol       Date:  2009-02-09       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.